175 related articles for article (PubMed ID: 16520445)
1. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature.
Lee JM; Davis MM; Clark SJ; Hofer TP; Kemper AR
Arch Pediatr Adolesc Med; 2006 Mar; 160(3):263-9. PubMed ID: 16520445
[TBL] [Abstract][Full Text] [Related]
2. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
[TBL] [Abstract][Full Text] [Related]
4. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
5. Use of growth hormone in non-growth hormone deficient children.
Sood A; Menon PS
Natl Med J India; 1998; 11(5):222-5. PubMed ID: 10997170
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone use in the treatment of idiopathic short stature.
Zucchini S
Curr Opin Investig Drugs; 2008 Apr; 9(4):396-401. PubMed ID: 18393106
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
8. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
Park P; Cohen P
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone use in children: necessary or designer therapy?
Ferguson LA
J Pediatr Health Care; 2011; 25(1):24-30. PubMed ID: 21147404
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
Toumba M; Bacopoulou I; Savva SC; Skordis N
Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
[TBL] [Abstract][Full Text] [Related]
12. Developments in idiopathic short stature: cost versus allocation of resources.
Durand-Zaleski I
Horm Res Paediatr; 2011; 76 Suppl 3():33-5. PubMed ID: 21912159
[TBL] [Abstract][Full Text] [Related]
13. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
Frindik JP; Morales A; Fowlkes J; Kemp S; Thrailkill K; Lippe B; Dana K
Horm Res; 2009; 72(3):160-6. PubMed ID: 19729947
[TBL] [Abstract][Full Text] [Related]
14. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
[TBL] [Abstract][Full Text] [Related]
15. Clinician and payer issues in managing growth hormone deficiency.
Owens GM
Am J Manag Care; 2000 Sep; 6(15 Suppl):S839-52; quiz S853-5. PubMed ID: 11184425
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders.
Rosenfeld R; Allen DB; MacGillivray MH; Alter C; Saenger P; Anhalt H; Hintz R; Katz HP
Am J Manag Care; 2000 Sep; 6(15 Suppl):S805-16. PubMed ID: 11184422
[TBL] [Abstract][Full Text] [Related]
17. The chasm: what can be done, and what should be done.
Brown E
Physician Exec; 1997 Feb; 23(2):39-41. PubMed ID: 10164976
[TBL] [Abstract][Full Text] [Related]
18. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
Hilczer M; Smyczyńska J; Lewiński A
Neuro Endocrinol Lett; 2006; 27(1-2):149-52. PubMed ID: 16648787
[TBL] [Abstract][Full Text] [Related]
19. Recombinant growth hormone for idiopathic short stature in children and adolescents.
Bryant J; Baxter L; Cave CB; Milne R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004440. PubMed ID: 17636758
[TBL] [Abstract][Full Text] [Related]
20. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
